Gómez-Peregrina, David
García-Valverde, Alfonso
Pilco-Janeta, Daniel
Serrano, César http://orcid.org/0000-0003-1416-8739
Article History
Accepted: 18 January 2021
First Online: 27 February 2021
Declarations
:
: David Gómez-Peregrina declares that he has no conflict of interest. Alfonso García-Valverde declares that he has no conflict of interest. Daniel Pilco-Janeta has received travel grants from Pfizer, Roemmers, and Roche. César Serrano has received research funding (paid to his institution) from Karyopharm Therapeutics, Pfizer, Deciphera Pharmaceuticals, and Bayer AG; has received consulting fees (advisory role) from Immunicum AB, Deciphera Pharmaceuticals, and Blueprint Medicines; has received payment for lectures from Bayer AG and Blueprint Medicines; and has received travel grants from PharmaMar, Pfizer, Bayer AG, Novartis, and Lilly